AHR and metabolic syndrome: This finding is in line with preclinical and clinical studies in a metabolic syndrome context, in which the gut microbiota produced smaller amounts of aryl hydrocarbon receptor agonists.55 Changes in the abundance of several tryptophan metabolites were observed in SARS-CoV-2-infected hamsters.